IBD and Mucosal Inflammation, Immunology, and Microbiology of the GI Tract
IBD and Mucosal Inflammation, Immunology, and Microbiology of the GI Tract
批准号:
8388772
负责人:
EUGENE B CHANG
金额:
$108.91万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-12-01 至 2015-11-30
关键词:
AnimalsAreaAuthorshipAwardBasic ScienceBiological SciencesBiologyBiomedical ResearchBudgetsCellsCellular biologyChicagoClinicalClinical ResearchClinical TreatmentCollaborationsContinuing EducationCore FacilityDataDevelopmentDiagnosisDigestive System DisordersDirect CostsDiseaseDocumentationEffectivenessEnteralEnvironmentEpithelialEquipmentExtramural ActivitiesFacultyFundingFutureGastrointestinal tract structureGenerationsGeneticGenomicsGeographic LocationsGnotobioticHospitalsHumanHuman ResourcesImmunologyInflammationInflammatoryInflammatory Bowel DiseasesInflammatory disease of the intestineInterdisciplinary StudyIntestinesInvestigationLaboratoriesLeadershipLinkMicrobeMicrobiologyMolecularMonitorMucositisMusNational Institute of Diabetes and Digestive and Kidney DiseasesParticipantPatientsProgress ReportsPublicationsRecombinant DNARecording of previous eventsReportingResearchResearch PersonnelResearch Project GrantsResearch TrainingScholarshipScientistServicesStructureSystemTalentsTechnologyTimeTissue EngineeringTrainingTranslational ResearchUniversitiesbasecareercost effectivegastrointestinalinterestmedical schoolsmembermicrobiomemicroorganismmultidisciplinarynew technologyoutreachprogramsresearch studysuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This application is for the competitive renewal of the Digestive Diseases Research Core Center (DDRCC) at the University of Chicago which has been in existence since 1990. The overarching theme of this DDRCC is the study of inflammatory bowel diseases (IBD) and IBD-related areas, including the immunology, microbiology, and genetics of Gl inflammatory disorders. Over the past funding cycle, the leadership, administrative structure, and research base of the DDRCC have provided a constancy that has been conducive to the development of robust and interactive networks among DDRCC members. The research base is highly multidisciplinary and currently has an annual total direct cost of $11.6 million, of which 40% or $4.65 million is supported by NIDDK. This amount is slightly greater than that reported for the last competitive renewal. The level of scholarship continues to be outstanding where over 40% of the resulting publications involve shared authorships among DDRCC members. The Pilot and Feasibility program has successfully promoted the development of new investigators and attracted established scientists from other fields to the study of IBD. The novelty and merits of their projects have led to a very high success rate in obtaining subsequent extramural funding. The enrichment program has provided continuing education and training for DDRCC members and, through its interactive programs, several new programmatic initiatives have emerged. With the rapid advances in the field and the emergence of new technologies, the DDRCC has successfully anticipated the needs and activities of DDRCC investigators. The Integrated Translational core (replacing the clinical component) has become a major underpinning of the DDRCC, linking clinical and basic research and creating unprecedented opportunities for collaborative translational research. The Host-Microbe core (formerly the Cell Biology core) provides a wide range of experimental systems to understand host-microbe interactions, including gnotobiotic mouse technology and new generation molecular approaches for studying the enteric microbiome. The Genomics and Molecular Engineering and Tissue and Cell Analysis Cores have also evolved to provide cutting edge technologies applicable to human-based and experimental research. In summary, the DDRCC has proactively promoted interaction and collaboration among its members. Through its cost-effective, enabling technologies and services, the DDRCC has been a major factor in the advancement of scholarship and discovery in IBD and digestive diseases at the University of Chicago.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Host and microbial basis of human ulcerative colitis and pouchitis: Identification, role, mechanisms, and resource development of host susceptibility and pathobiont factors
-
批准号:9816394
-
项目类别:
-
资助金额:$206.37万
-
财政年份:2019
-
负责人:EUGENE B CHANG
-
依托单位:
Conceptual and mechanistic insights into the development of diet-induced obesity through disruption of hepatic circadian rhythms by the gut microbiome
-
批准号:10066345
-
项目类别:
-
资助金额:$58.8万
-
财政年份:2019
-
负责人:EUGENE B CHANG
-
依托单位:
Conceptual and mechanistic insights into the development of diet-induced obesity through disruption of hepatic circadian rhythms by the gut microbiome
-
批准号:10308705
-
项目类别:
-
资助金额:$58.8万
-
财政年份:2019
-
负责人:EUGENE B CHANG
-
依托单位:
Host and microbial basis of human ulcerative colitis and pouchitis: Identification, role, mechanisms, and resource development of host susceptibility and pathobiont factors
-
批准号:10403677
-
项目类别:
-
资助金额:$204.09万
-
财政年份:2019
-
负责人:EUGENE B CHANG
-
依托单位:
Host and microbial basis of human ulcerative colitis and pouchitis: Identification, role, mechanisms, and resource development of host susceptibility and pathobiont factors
-
批准号:10004050
-
项目类别:
-
资助金额:$204.09万
-
财政年份:2019
-
负责人:EUGENE B CHANG
-
依托单位:
Host and microbial basis of human ulcerative colitis and pouchitis: Identification, role, mechanisms, and resource development of host susceptibility and pathobiont factors
-
批准号:10626047
-
项目类别:
-
资助金额:$204.09万
-
财政年份:2019
-
负责人:EUGENE B CHANG
-
依托单位:
Diet induced obesity from gut microbial disruption of host metabolic networks
-
批准号:9129870
-
项目类别:
-
资助金额:$40.9万
-
财政年份:2015
-
负责人:EUGENE B CHANG
-
依托单位:
Dietary fat effects on gut microbes, host immune state and experimental colitis
-
批准号:8890155
-
项目类别:
-
资助金额:$46.28万
-
财政年份:2012
-
负责人:EUGENE B CHANG
-
依托单位:
Dietary fat effects on gut microbes, host immune state and experimental colitis
-
批准号:8421583
-
项目类别:
-
资助金额:$43.55万
-
财政年份:2012
-
负责人:EUGENE B CHANG
-
依托单位:
Dietary fat effects on gut microbes, host immune state and experimental colitis
-
批准号:8717657
-
项目类别:
-
资助金额:$42.13万
-
财政年份:2012
-
负责人:EUGENE B CHANG
-
依托单位:
Dietary fat effects on gut microbes, host immune state and experimental colitis
-
批准号:8549226
-
项目类别:
-
资助金额:$40.7万
-
财政年份:2012
-
负责人:EUGENE B CHANG
-
依托单位:
The Role of the Gut Microbiota in Ulcerative Colitis
-
批准号:8111530
-
项目类别:
-
资助金额:$300.0万
-
财政年份:2009
-
负责人:EUGENE B CHANG
-
依托单位:
The Role of the Gut Microbiota in Ulcerative Colitis
-
批准号:7645981
-
项目类别:
-
资助金额:$108.78万
-
财政年份:2009
-
负责人:EUGENE B CHANG
-
依托单位:
The Role of the Gut Microbiota in Ulcerative Colitis
-
批准号:8128681
-
项目类别:
-
资助金额:$261.9万
-
财政年份:2009
-
负责人:EUGENE B CHANG
-
依托单位:
The Role of the Gut Microbiota in Ulcerative Colitis
-
批准号:8308650
-
项目类别:
-
资助金额:$257.0万
-
财政年份:2009
-
负责人:EUGENE B CHANG
-
依托单位:
Cytoprotective Role of Heat Shock Proteins in IBD
-
批准号:7915843
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2009
-
负责人:EUGENE B CHANG
-
依托单位:
Technologies for the discovery of novel human colonic mucosal-associated microbes
-
批准号:7691833
-
项目类别:
-
资助金额:$22.6万
-
财政年份:2008
-
负责人:EUGENE B CHANG
-
依托单位:
Technologies for the discovery of novel human colonic mucosal-associated microbes
-
批准号:7571469
-
项目类别:
-
资助金额:$18.76万
-
财政年份:2008
-
负责人:EUGENE B CHANG
-
依托单位:
Cell & Microbiology Core
-
批准号:7499808
-
项目类别:
-
资助金额:$14.09万
-
财政年份:2006
-
负责人:EUGENE B CHANG
-
依托单位:
Administrative Core
-
批准号:7499806
-
项目类别:
-
资助金额:$30.79万
-
财政年份:2006
-
负责人:EUGENE B CHANG
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: